Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors. - Caulfield JI; Aizenbud L; Perdigoto AL; Meffre E; Jilaveanu L; Michalek DA; Rich SS; Aizenbud Y; Adeniran A; Herold KC; Austin MR; Kluger H (Journal for immunotherapy of cancer, 2023)